Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- KavaPKIndependent statistical analysis of Biomarker Changes and Anxiolytic Effects-Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565145).
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03919799).
- KEEPsAKE 1Independent statistical analysis of A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease…
- KEIFER SSTIndependent statistical analysis of Self Selection Trial of Naproxen Sodium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01383486).
- Ket-RSIIndependent statistical analysis of Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KETAFAPIndependent statistical analysis of Ketamine For Acute Treatment of Pain in Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02306759).
- KETAMINEIndependent statistical analysis of Administration of Ketamine to Prevent the Post-operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00210210).
- Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02643979).
- Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03431285).
- Ketamine in Borderline Personality Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine in Borderline Personality Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395314).
- Ketamine Patient-Controlled Analgesia for Acute Pain: Complete Statistical AnalysisIndependent statistical analysis of Ketamine Patient-Controlled Analgesia for Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02062879).
- Ketoconazole Foam 2% for the Treatment of Versicolor: Complete Statistical AnalysisIndependent statistical analysis of Ketoconazole Foam 2% for the Treatment of Versicolor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00830388).
- Ketogenic Diet (KD) in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Ketogenic Diet (KD) in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255031).
- KEYNOTE-782Independent statistical analysis of Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Kharitode TBIndependent statistical analysis of Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02808507).
- KHLADIndependent statistical analysis of Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00953576).
- Kick Out Parkinson’s Disease 2: Complete Statistical AnalysisIndependent statistical analysis of Kick Out Parkinson's Disease 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03882879).
- Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: Complete Statistical AnalysisIndependent statistical analysis of Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Kids ALONGIndependent statistical analysis of Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A: primary endpoint results,…
- KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).
- Kinetic Anesthesia Device Study: Complete Statistical AnalysisIndependent statistical analysis of Kinetic Anesthesia Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344510).
- KINGIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- KINGFISHERIndependent statistical analysis of Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- kINSHIPIndependent statistical analysis of HIV Prevention Peer Navigation for Justice Involved Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04680390).
- KIU!Independent statistical analysis of Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men: primary endpoint results, effect estimate with confidence interval,…
- KL4-AHRF-01Independent statistical analysis of Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne: Complete Statistical AnalysisIndependent statistical analysis of Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Kokkerelli Learning Street Effect Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Kokkerelli Learning Street Effect Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04190680).
- KONDUCTIndependent statistical analysis of Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- KontRASt-06Independent statistical analysis of Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1…
- KP415 Classroom Study in Children (6-12 Years of Age) With ADHD: Complete Statistical AnalysisIndependent statistical analysis of KP415 Classroom Study in Children (6-12 Years of Age) With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KPZIndependent statistical analysis of Suicide Prevention Integration Into Task-shifted Mental Health Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06208293).
- L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: Complete Statistical AnalysisIndependent statistical analysis of L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733407).
- L12-078Independent statistical analysis of Pain Control With Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680549).
- Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: Complete Statistical AnalysisIndependent statistical analysis of Labetalol and Esmolol: Vital Signs and Post Operative Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114971).
- LABYRIndependent statistical analysis of Wayfinding Intervention in High-Fidelity Long-Term Memory: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04253587).
- LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).
- LAG-3/IMP321Independent statistical analysis of Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01308294).
- LAIVIndependent statistical analysis of A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LAL1610Independent statistical analysis of Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lamotrigine 25 mg Chewable Tablets, Non-Fasting: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine 25 mg Chewable Tablets, Non-Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00838136).
- Lamotrigine Bioequivalence: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Bioequivalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01995825).
- Lamotrigine Monotherapy in Pediatric Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Monotherapy in Pediatric Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00176228).
- Lamotrigine Pregnancy Registry (LAM05): Complete Statistical AnalysisIndependent statistical analysis of Lamotrigine Pregnancy Registry (LAM05): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01064297).
- LAMPIndependent statistical analysis of Learning to Apply Mindfulness to Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04526158).
- Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: Complete Statistical AnalysisIndependent statistical analysis of Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383708).
- Laparoscopic Versus Open Appendectomy? Let the Patient Decide: Complete Statistical AnalysisIndependent statistical analysis of Laparoscopic Versus Open Appendectomy? Let the Patient Decide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01738750).